LVW Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,267
Closed -$339K 224
2022
Q2
$339K Buy
17,267
+487
+3% +$11.5K 0.07% 176
2022
Q1
$438K Sell
16,780
-808
-5% -$21.5K 0.07% 160
2021
Q4
$499K Sell
17,588
-590
-3% -$18.4K 0.09% 148
2021
Q3
$580K Buy
18,178
+265
+1% +$8.89K 0.1% 140
2021
Q2
$621K Sell
17,913
-950
-5% -$31.3K 0.11% 131
2021
Q1
$556K Buy
18,863
+5,838
+45% +$180K 0.11% 135
2020
Q4
$399K Buy
13,025
+4,938
+61% +$151K 0.08% 140
2020
Q3
$226K Buy
+8,087
New +$205K 0.05% 176

Other funds holding ELAN

LVW Advisors's ELAN Position: Q3 2022 in Review

LVW Advisors sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 17,267 shares — an estimated $339K sold.

LVW Advisors first reported a position in ELAN in Q3 2020 and held it in 8 quarters. The position peaked at $621K in Q2 2021. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • LVW Advisors reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
  • LVW Advisors sold 17,267 Elanco Animal Health shares in Q3 2022, an estimated $339K.
  • LVW Advisors first reported a position in Elanco Animal Health in Q3 2020 and held it in 8 quarters.
  • LVW Advisors's Elanco Animal Health position peaked at $621K in Q2 2021.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on LVW Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.